Islet transplantation in type 1 diabetics with hypoglycemic unawareness using abatacept as a
part of a novel calcineurin-inhibitor-sparing immunosuppressive regimen.
Islet transplantation in type 1 diabetics with hypoglycemic unawareness using abatacept as a
part of a novel calcineurin-inhibitor-sparing immunosuppressive regimen.
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Terminated
Immune Tolerance Network (ITN)
Phase 2
2006-12-01
Belatacept is an experimental medication shown in clinical trials to have immune system
suppression properties in people who have had renal (e.g., kidney) transplants. This study
will determine whether a combination of anti-rejection drugs, including belatacept, can
prevent the rejection of a first-time, non-human leukocyte antigen (HLA) identical renal
transplant and allow patients to be safely withdrawn from anti-rejection therapy one year
post-transplant.
Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
Terminated
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 2
2006-12-01
Belatacept is an experimental medication shown in clinical trials to have immune system
suppression properties in people who have had renal (e.g., kidney) transplants. This study
will determine whether a combination of anti-rejection drugs, including belatacept, can
prevent the rejection of a first-time, non-human leukocyte antigen (HLA) identical renal
transplant and allow patients to be safely withdrawn from anti-rejection therapy one year
post-transplant.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
